RecallRadar

FDA Drug recall D-0134-2020

Benazepril HCl Tablets, USP 40 mg, 100 count bottles, Rx only, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ NDC 65162-754-10

On 2019-10-16 the FDA classified a Class III recall of Benazepril HCl Tablets, USP 40 mg, 100 count bottles, Rx only, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ NDC 65162-754-10 by Amneal Pharmaceuticals, citing presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0134-2020
ClassificationClass III
Statusterminated
Initiated2019-09-24
Published2019-10-16
Last updated2026-09-13 11:52 UTC
CompanyAmneal Pharmaceuticals
DistributionUS

Product

Benazepril HCl Tablets, USP 40 mg, 100 count bottles, Rx only, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ NDC 65162-754-10

Reason

Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle

Identifiers

ndc65162-751-03
ndc65162-751-10
ndc65162-751-50
ndc65162-752-03
ndc65162-752-10
ndc65162-752-50
ndc65162-753-03
ndc65162-753-10
ndc65162-753-50
ndc65162-754-03
ndc65162-754-10
ndc65162-754-50
code_infoLot # BB02619A, exp. date 04/2021

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0134-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.